Boehringer Ingelheim’s Jascayd has received European marketing authorisation for idiopathic [...]

Cereno Scientific has broadened the clinical development focus of its [...]

Qureight, a techbio company advancing the understanding of lung and [...]

Cereno Scientific, a biotechnology company pioneering treatments for rare cardiovascular [...]

Qureight’s deep-learning biomarkers confirm representativeness of Insilico’s Phase 2a IPF [...]